REQUEST A DEMO
Total
USD $0.00
Search more companies

Angiolab Inc. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Angiolab Inc. Profile Updated: June 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Angiolab Inc. is an enterprise located in South Korea, with the main office in Daejeon. It operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on May 22, 1999. Angiolab Inc. currently employs 11 - 50 (2025) people. There was a net sales revenue increase of 311.65% reported in Angiolab Inc.’s latest financial highlights for 2024. Over the same period, its total assets decreased by 41.82%. In 2024, Angiolab Inc.’s net profit margin increased by 428.43%.

Headquarters
65 Techno 3Ro, Yuseong-Gu
Daejeon; Daejeon;

Contact Details: Purchase the Angiolab Inc. report to view the information.

Website: http://www.angiolab.co.kr

Basic Information
Total Employees:
Purchase the Angiolab Inc. report to view the information.
Outstanding Shares:
Purchase the Angiolab Inc. report to view the information.
Financial Auditors:
Purchase the Angiolab Inc. report to view the information.
Incorporation Date:
May 22, 1999
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Subsidiaries
(주)안지오랩
Company Performance
Financial values in the chart are available after Angiolab Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
311.65%
Total Operating Revenue
306.23%
Operating Profit
65.08%
EBITDA
67.68%
Net Profit/Loss for the Period
65.79%
Total Assets
-41.82%
Total Equity
-39.48%
Operating Profit Margin
447.25%
Net Profit Margin
428.43%
Return on Equity (ROE)
51.24%
Debt / Equity
1.75%
Quick Ratio
-0.22%
Cash Ratio
0.68%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?